Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,381 public trials 841 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Active, Not Recruiting

A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

NCT07076121

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Mayo Clinic in Arizona - Phoenix Phoenix, Arizona, United States
  • Local Institution - 0365 Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 269 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06625320

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center - Phoenix Phoenix, Arizona, United States
  • City of Hope-Duarte Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT01585805

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Mercy Hospital Saint Louis St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

NCT06360354

Conditions
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

NCT03257761

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details

Related conditions